HEADER OXIDOREDUCTASE/INHIBITOR 19-JUL-23 8K4K TITLE CRYSTAL STRUCTURE OF HUMAN BILIVERDIN IX-BETA REDUCTASE B WITH TITLE 2 OLSALAZINE CARBON DERIVATIVE COMPND MOL_ID: 1; COMPND 2 MOLECULE: FLAVIN REDUCTASE (NADPH); COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: FR,BILIVERDIN REDUCTASE B,BVR-B,BILIVERDIN-IX BETA- COMPND 5 REDUCTASE,GREEN HEME-BINDING PROTEIN,GHBP,NADPH-DEPENDENT DIAPHORASE, COMPND 6 NADPH-FLAVIN REDUCTASE,FLR; COMPND 7 EC: 1.5.1.30,1.3.1.24; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: BLVRB, FLR; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS PLATELETS, NADP, OXIDOREDUCTASE-INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR J.H.HA,H.M.JUNG,M.V.C.DELA CERNA,J.A.BURLISON,D.LEE,K.S.RYU REVDAT 2 29-JAN-25 8K4K 1 JRNL REVDAT 1 22-JAN-25 8K4K 0 JRNL AUTH H.M.JUNG,J.H.HA,M.V.C.DELA CERNA,J.A.BURLISON,J.CHOI, JRNL AUTH 2 B.R.KIM,J.K.BANG,K.S.RYU,D.LEE JRNL TITL AN INNOVATIVE INHIBITOR WITH A NEW CHEMICAL MOIETY AIMED AT JRNL TITL 2 BILIVERDIN IX BETA REDUCTASE FOR THROMBOCYTOPENIA AND JRNL TITL 3 RESILIENT AGAINST CELLULAR DEGRADATION. JRNL REF PHARMACEUTICS V. 16 2024 JRNL REFN ESSN 1999-4923 JRNL PMID 39339186 JRNL DOI 10.3390/PHARMACEUTICS16091148 REMARK 2 REMARK 2 RESOLUTION. 1.70 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (1.19.2_4158: ???) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.70 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 33.91 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.350 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 3 NUMBER OF REFLECTIONS : 44963 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.163 REMARK 3 R VALUE (WORKING SET) : 0.161 REMARK 3 FREE R VALUE : 0.192 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.010 REMARK 3 FREE R VALUE TEST SET COUNT : 2253 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 33.9100 - 4.2800 1.00 2891 148 0.1575 0.1711 REMARK 3 2 4.2800 - 3.4000 1.00 2733 144 0.1441 0.1707 REMARK 3 3 3.4000 - 2.9700 1.00 2693 143 0.1594 0.1850 REMARK 3 4 2.9700 - 2.7000 1.00 2715 134 0.1720 0.1806 REMARK 3 5 2.7000 - 2.5100 1.00 2680 146 0.1653 0.2195 REMARK 3 6 2.5100 - 2.3600 1.00 2628 160 0.1660 0.2228 REMARK 3 7 2.3600 - 2.2400 1.00 2664 136 0.1637 0.1930 REMARK 3 8 2.2400 - 2.1400 1.00 2661 135 0.1622 0.1714 REMARK 3 9 2.1400 - 2.0600 1.00 2643 140 0.1518 0.1840 REMARK 3 10 2.0600 - 1.9900 1.00 2636 132 0.1601 0.1922 REMARK 3 11 1.9900 - 1.9300 1.00 2654 140 0.1697 0.2297 REMARK 3 12 1.9300 - 1.8700 1.00 2655 136 0.1754 0.2229 REMARK 3 13 1.8700 - 1.8200 1.00 2609 135 0.1759 0.2093 REMARK 3 14 1.8200 - 1.7800 1.00 2637 141 0.1710 0.2087 REMARK 3 15 1.7800 - 1.7400 1.00 2615 133 0.1718 0.2426 REMARK 3 16 1.7400 - 1.7000 0.99 2596 150 0.1879 0.2506 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.140 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 18.120 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.008 3342 REMARK 3 ANGLE : 1.057 4574 REMARK 3 CHIRALITY : 0.058 532 REMARK 3 PLANARITY : 0.008 576 REMARK 3 DIHEDRAL : 15.657 476 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 8K4K COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 21-JUL-23. REMARK 100 THE DEPOSITION ID IS D_1300039485. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 23-JUN-21 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : PAL/PLS REMARK 200 BEAMLINE : 5C (4A) REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97957 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS EIGER X 9M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 44971 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.700 REMARK 200 RESOLUTION RANGE LOW (A) : 33.910 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : 9.300 REMARK 200 R MERGE (I) : 0.05728 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 23.0300 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.70 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.76 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.25440 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 3.830 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHENIX REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 44.38 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.21 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 1.9~2.0M AMMONIUM SULFATE, 0.1M BIS REMARK 280 -TRIS, PH 6.5, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X+1/2,Y+1/2,-Z REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 41.07150 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 58.65200 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 41.07150 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 58.65200 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 4810 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 17230 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -23.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A 560 LIES ON A SPECIAL POSITION. REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ARG B 170 CG CD NE CZ NH1 NH2 REMARK 470 ARG B 174 CG CD NE CZ NH1 NH2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 NH1 ARG A 140 O1 GOL B 301 2.05 REMARK 500 O HOH A 596 O HOH A 679 2.17 REMARK 500 O HOH A 643 O HOH B 509 2.18 REMARK 500 O HOH A 506 O HOH A 644 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 O HOH A 679 O HOH A 679 2555 2.08 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 MET A 185 CA - CB - CG ANGL. DEV. = 12.3 DEGREES REMARK 500 MET B 185 CA - CB - CG ANGL. DEV. = 10.8 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG A 78 -129.23 52.93 REMARK 500 THR A 110 -104.84 -112.69 REMARK 500 PRO A 152 -146.30 -83.60 REMARK 500 ALA B 2 102.14 -56.83 REMARK 500 THR B 110 -110.42 -116.84 REMARK 500 PRO B 152 -146.48 -81.22 REMARK 500 PRO B 172 -100.16 -48.76 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A 684 DISTANCE = 5.83 ANGSTROMS REMARK 525 HOH B 566 DISTANCE = 7.34 ANGSTROMS DBREF 8K4K A 1 206 UNP P30043 BLVRB_HUMAN 1 206 DBREF 8K4K B 1 206 UNP P30043 BLVRB_HUMAN 1 206 SEQRES 1 A 206 MET ALA VAL LYS LYS ILE ALA ILE PHE GLY ALA THR GLY SEQRES 2 A 206 GLN THR GLY LEU THR THR LEU ALA GLN ALA VAL GLN ALA SEQRES 3 A 206 GLY TYR GLU VAL THR VAL LEU VAL ARG ASP SER SER ARG SEQRES 4 A 206 LEU PRO SER GLU GLY PRO ARG PRO ALA HIS VAL VAL VAL SEQRES 5 A 206 GLY ASP VAL LEU GLN ALA ALA ASP VAL ASP LYS THR VAL SEQRES 6 A 206 ALA GLY GLN ASP ALA VAL ILE VAL LEU LEU GLY THR ARG SEQRES 7 A 206 ASN ASP LEU SER PRO THR THR VAL MET SER GLU GLY ALA SEQRES 8 A 206 ARG ASN ILE VAL ALA ALA MET LYS ALA HIS GLY VAL ASP SEQRES 9 A 206 LYS VAL VAL ALA CYS THR SER ALA PHE LEU LEU TRP ASP SEQRES 10 A 206 PRO THR LYS VAL PRO PRO ARG LEU GLN ALA VAL THR ASP SEQRES 11 A 206 ASP HIS ILE ARG MET HIS LYS VAL LEU ARG GLU SER GLY SEQRES 12 A 206 LEU LYS TYR VAL ALA VAL MET PRO PRO HIS ILE GLY ASP SEQRES 13 A 206 GLN PRO LEU THR GLY ALA TYR THR VAL THR LEU ASP GLY SEQRES 14 A 206 ARG GLY PRO SER ARG VAL ILE SER LYS HIS ASP LEU GLY SEQRES 15 A 206 HIS PHE MET LEU ARG CYS LEU THR THR ASP GLU TYR ASP SEQRES 16 A 206 GLY HIS SER THR TYR PRO SER HIS GLN TYR GLN SEQRES 1 B 206 MET ALA VAL LYS LYS ILE ALA ILE PHE GLY ALA THR GLY SEQRES 2 B 206 GLN THR GLY LEU THR THR LEU ALA GLN ALA VAL GLN ALA SEQRES 3 B 206 GLY TYR GLU VAL THR VAL LEU VAL ARG ASP SER SER ARG SEQRES 4 B 206 LEU PRO SER GLU GLY PRO ARG PRO ALA HIS VAL VAL VAL SEQRES 5 B 206 GLY ASP VAL LEU GLN ALA ALA ASP VAL ASP LYS THR VAL SEQRES 6 B 206 ALA GLY GLN ASP ALA VAL ILE VAL LEU LEU GLY THR ARG SEQRES 7 B 206 ASN ASP LEU SER PRO THR THR VAL MET SER GLU GLY ALA SEQRES 8 B 206 ARG ASN ILE VAL ALA ALA MET LYS ALA HIS GLY VAL ASP SEQRES 9 B 206 LYS VAL VAL ALA CYS THR SER ALA PHE LEU LEU TRP ASP SEQRES 10 B 206 PRO THR LYS VAL PRO PRO ARG LEU GLN ALA VAL THR ASP SEQRES 11 B 206 ASP HIS ILE ARG MET HIS LYS VAL LEU ARG GLU SER GLY SEQRES 12 B 206 LEU LYS TYR VAL ALA VAL MET PRO PRO HIS ILE GLY ASP SEQRES 13 B 206 GLN PRO LEU THR GLY ALA TYR THR VAL THR LEU ASP GLY SEQRES 14 B 206 ARG GLY PRO SER ARG VAL ILE SER LYS HIS ASP LEU GLY SEQRES 15 B 206 HIS PHE MET LEU ARG CYS LEU THR THR ASP GLU TYR ASP SEQRES 16 B 206 GLY HIS SER THR TYR PRO SER HIS GLN TYR GLN HET GOL A 401 6 HET GOL A 402 6 HET GOL A 403 6 HET SO4 A 404 5 HET NAP A 405 48 HET VE2 A 406 22 HET GOL B 301 6 HET NAP B 302 48 HET VE2 B 303 22 HETNAM GOL GLYCEROL HETNAM SO4 SULFATE ION HETNAM NAP NADP NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE HETNAM VE2 5-[(E)-2-(3-CARBOXY-4-OXIDANYL-PHENYL)ETHENYL]-2- HETNAM 2 VE2 OXIDANYL-BENZOIC ACID HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL HETSYN NAP 2'-MONOPHOSPHOADENOSINE 5'-DIPHOSPHORIBOSE FORMUL 3 GOL 4(C3 H8 O3) FORMUL 6 SO4 O4 S 2- FORMUL 7 NAP 2(C21 H28 N7 O17 P3) FORMUL 8 VE2 2(C16 H12 O6) FORMUL 12 HOH *350(H2 O) HELIX 1 AA1 GLY A 13 ALA A 26 1 14 HELIX 2 AA2 GLN A 57 ALA A 66 1 10 HELIX 3 AA3 THR A 85 GLY A 102 1 18 HELIX 4 AA4 SER A 111 TRP A 116 5 6 HELIX 5 AA5 ASP A 117 VAL A 121 5 5 HELIX 6 AA6 PRO A 122 ARG A 124 5 3 HELIX 7 AA7 LEU A 125 SER A 142 1 18 HELIX 8 AA8 LYS A 178 CYS A 188 1 11 HELIX 9 AA9 LEU A 189 THR A 191 5 3 HELIX 10 AB1 GLY B 13 GLY B 27 1 15 HELIX 11 AB2 ASP B 36 LEU B 40 5 5 HELIX 12 AB3 GLN B 57 ALA B 66 1 10 HELIX 13 AB4 THR B 85 GLY B 102 1 18 HELIX 14 AB5 SER B 111 TRP B 116 5 6 HELIX 15 AB6 ASP B 117 VAL B 121 5 5 HELIX 16 AB7 PRO B 122 ARG B 124 5 3 HELIX 17 AB8 LEU B 125 GLU B 141 1 17 HELIX 18 AB9 LYS B 178 CYS B 188 1 11 HELIX 19 AC1 LEU B 189 THR B 191 5 3 SHEET 1 AA1 8 HIS A 49 VAL A 52 0 SHEET 2 AA1 8 GLU A 29 VAL A 34 1 N VAL A 32 O VAL A 51 SHEET 3 AA1 8 LYS A 5 PHE A 9 1 N ILE A 6 O THR A 31 SHEET 4 AA1 8 ALA A 70 VAL A 73 1 O ILE A 72 N ALA A 7 SHEET 5 AA1 8 LYS A 105 CYS A 109 1 O VAL A 107 N VAL A 73 SHEET 6 AA1 8 LYS A 145 VAL A 149 1 O VAL A 147 N VAL A 106 SHEET 7 AA1 8 SER A 198 SER A 202 1 O THR A 199 N ALA A 148 SHEET 8 AA1 8 THR A 164 LEU A 167 -1 N THR A 164 O SER A 202 SHEET 1 AA2 2 HIS A 153 GLY A 155 0 SHEET 2 AA2 2 VAL A 175 SER A 177 1 O ILE A 176 N HIS A 153 SHEET 1 AA3 8 HIS B 49 VAL B 52 0 SHEET 2 AA3 8 GLU B 29 VAL B 34 1 N VAL B 32 O VAL B 51 SHEET 3 AA3 8 LYS B 5 PHE B 9 1 N ILE B 6 O THR B 31 SHEET 4 AA3 8 ALA B 70 VAL B 73 1 O ILE B 72 N ALA B 7 SHEET 5 AA3 8 LYS B 105 CYS B 109 1 O VAL B 107 N VAL B 71 SHEET 6 AA3 8 LYS B 145 VAL B 149 1 O LYS B 145 N VAL B 106 SHEET 7 AA3 8 SER B 198 SER B 202 1 O THR B 199 N ALA B 148 SHEET 8 AA3 8 THR B 164 LEU B 167 -1 N THR B 164 O SER B 202 SHEET 1 AA4 2 HIS B 153 GLY B 155 0 SHEET 2 AA4 2 VAL B 175 SER B 177 1 O ILE B 176 N HIS B 153 CRYST1 82.143 117.304 41.559 90.00 90.00 90.00 P 21 21 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.012174 0.000000 0.000000 0.00000 SCALE2 0.000000 0.008525 0.000000 0.00000 SCALE3 0.000000 0.000000 0.024062 0.00000